# Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans

> **NCT00422253** · NA · COMPLETED · sponsor: **Bayside Health** · enrollment: 27 (actual)

## Conditions studied

- Type 2 Diabetes
- Insulin Resistance
- Obesity

## Interventions

- **BEHAVIORAL:** dietary intervention

## Key facts

- **NCT ID:** NCT00422253
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2013-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422253, "Dietary Advanced Glycation End-products and Insulin Resistance in Overweight and Obese Humans". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00422253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*